RRC ID 44380
Author Sakurai Y, Hatakeyama H, Sato Y, Hyodo M, Akita H, Harashima H.
Title Gene silencing via RNAi and siRNA quantification in tumor tissue using MEND, a liposomal siRNA delivery system.
Journal Mol Ther
Abstract Small interfering RNA (siRNA) would be predicted to function as a cancer drug, but an efficient siRNA delivery system is required for clinical development. To address this issue, we developed a liposomal siRNA carrier, a multifunctional envelope-type nanodevice (MEND). We previously reported that a MEND composed of a pH-sensitive cationic lipid, YSK05, showed significant knockdown in both in vitro and in tumor tissue by intratumoral injection. Here, we report on the development of an in vivo siRNA delivery system that is delivered by systemic injection and an analysis of the pharmacokinetics of an intravenously administered siRNA molecule in tumor tissue. Tumor delivery of siRNA was quantified by means of stem-loop primer quantitative reverse transcriptase PCR (qRT-PCR) method. PEGylation of the YSK-MEND results in the increase in the accumulation of siRNA in tumor tissue from 0.0079% ID/g tumor to 1.9% ID/g tumor. The Administration of the MEND (3 mg siRNA/kg body weight) showed about a 50% reduction in the target gene mRNA and protein. Moreover, we verified the induction of RNA interference by 5' RACE-PCR method. The collective results reported here indicate that an siRNA carrier was developed that can deliver siRNA to a target cell in tumor tissue through an improved siRNA bioavailability.
Volume 21(6)
Pages 1195-203
Published 2013-6-1
DOI 10.1038/mt.2013.57
PII S1525-0016(16)32613-2
PMID 23568259
PMC PMC3677313
MeSH Administration, Intravenous Amino Acid Sequence Animals Cell Line, Tumor Gene Transfer Techniques* Humans Lipids / pharmacology Liposomes / chemistry* Male Mice Mice, Inbred BALB C Mice, Inbred ICR Microscopy, Confocal Molecular Sequence Data Neoplasms / therapy* Piperidines / pharmacology Polyethylene Glycols / metabolism RNA Interference* RNA, Messenger / antagonists & inhibitors RNA, Messenger / genetics RNA, Messenger / metabolism RNA, Small Interfering / administration & dosage* Toxicity Tests
IF 8.986
Times Cited 82
WOS Category BIOTECHNOLOGY & APPLIED MICROBIOLOGY MEDICINE, RESEARCH & EXPERIMENTAL GENETICS & HEREDITY
Resource
Human and Animal Cells OS-RC-2(RCB0735)